Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis

Published:2013-04-01 Issue:4 Volume:70 Page:469
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Kornek Barbara,Aboul-Enein Fahmy,Rostasy Kevin,Milos Ruxandra-Iulia,Steiner Irene,Penzien Johann,Hellwig Kerstin,Pitarokoili Kalliopi,Storm van's Gravesande Karin,Karenfort Michael,Blaschek Astrid,Meyer Andreas,Seidl Rainer,Debelic Diana,Vass Karl,Prayer Daniela,Kristoferitsch Wolfgang,Bayas Antonios

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis;Neurology Neuroimmunology & Neuroinflammation;2024-09

2. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab;Multiple Sclerosis and Related Disorders;2024-07

3. Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approach;Neurology and Therapy;2024-06-01

4. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries;The Lancet Child & Adolescent Health;2024-05

5. Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis;Neurology;2024-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP